← FDA Drug Approvals (Drugs@FDA)

PLERIXAFOR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2023-07-24

Drug application

FDA Application #

ANDA215698

Application type

Abbreviated New Drug Application (Generic)

Brand name

PLERIXAFOR

Generic name

PLERIXAFOR

Active ingredients

PLERIXAFOR

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

MEITHEAL

Manufacturer

Meitheal Pharmaceuticals Inc.

First approval

2023-07-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown